ACA

NEUTRALM&A

Arcosa, Inc.

2026-08-06

Price

$144.89

-0.30%

This is the 2026-08-06 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score10.5Top Tier

Signals5/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.2xvs 20d avg

Analysis

Arcosa's minor Q2 earnings miss is entirely irrelevant noise, as the stock's price action is structurally anchored to CRH's pending $150 per share all-cash acquisition. Strong technical signals like STEADY_CLIMB and PERFECT_STACK reflect institutional absorption and high confidence in the deal's completion. Furthermore, the current RISK_ON macro regime, highlighted by remarkably tight 0.78% credit spreads, guarantees abundant liquidity for CRH to finance the $8.5 billion buyout without friction.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACKDISTRIBUTION

Key Takeaways

M&A Anchor: The pending $150/share all-cash buyout by CRH overrides recent earnings data, turning ACA into a pure merger arbitrage play.
Macro Tailwind: The highly liquid RISK_ON environment and tight credit spreads drastically reduce the financing and completion risks for the acquirer.
Actionable Setup: The current price of $144.89 offers a defined arbitrage spread into the September 4 shareholder vote, with hard support at $144.65.

← Back to 2026-08-06 View Full ACA History →Yahoo Finance &nearr;